Developing Oral LT3 Therapy for Heart Failure - HFrEF

Clinical trial NCT04112316 · COMPLETED

Trial details

NCT number: NCT04112316
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction (HFrEF)Low T3 Syndrome

Start date: 2020-02-11
Primary completion: 2023-10-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.